Part of the Technology Updates series, this fact sheet describes PATH's work to develop an oxytocin sublingual fast-dissolving tablet presentation that dissolves in less than ten seconds in the patient’s mouth without the need for additional water or diluent. Oxytocin in this type of presentation could potentially increase the reach and efficacy of this lifesaving medication to areas lacking access to skilled health workers, refrigeration, or safe injection equipment.

Corporate author(s): PATH

Publication date: May 2014

Available materials


Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

This publication is part of the series Technology Updates

Related regions: Global

See also:

For more information…

Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA